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Abstract
Background: Despite the near ubiquity of mobile phones, little research has been conducted on the implementation of mobile
health (mHealth) apps to treat patients in primary care. Although primary care clinicians routinely treat chronic conditions such
as asthma and diabetes, they rarely treat addiction, a common chronic condition. Instead, addiction is most often treated in the
US health care system, if it is treated at all, in a separate behavioral health system. mHealth could help integrate addiction treatment
in primary care.
Objective: The objective of this paper was to report the effects of implementing an mHealth system for addiction in primary
care on both patients and clinicians.
Methods: In this implementation research trial, an evidence-based mHealth system named Seva was introduced sequentially
over 36 months to a maximum of 100 patients with substance use disorders (SUDs) in each of three federally qualified health
centers (FQHCs; primary care clinics that serve patients regardless of their ability to pay). This paper reports on patient and
clinician outcomes organized according to the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM)
framework.
Results: The outcomes according to the RE-AIM framework are as follows: Reach—Seva reached 8.31% (268/3226) of
appropriate patients. Reach was limited by our ability to pay for phones and data plans for a maximum of 100 patients per clinic.
Effectiveness—Patients who were given Seva had significant improvements in their risky drinking days (44% reduction,
(0.7-1.25)/1.25, P=.04), illicit drug-use days (34% reduction, (2.14-3.22)/3.22, P=.01), quality of life, human immunodeficiency
virus screening rates, and number of hospitalizations. Through Seva, patients also provided peer support to one another in ways
that are novel in primary care settings. Adoption—Patients sustained high levels of Seva use—between 53% and 60% of the
patients at the 3 sites accessed Seva during the last week of the 12-month implementation period. Among clinicians, use of the
technology was less robust than use by patients, with only a handful of clinicians using Seva in each clinic and behavioral health
providers making most referrals to Seva in 2 of the 3 clinics. Implementation—At 2 sites, implementation plans were realized
successfully; they were delayed in the third. Maintenance—Use of Seva dropped when grant funding stopped paying for the
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mobile phones and data plans. Two of the 3 clinics wanted to maintain the use of Seva, but they struggled to find funding to
support this.
Conclusions: Implementing an mHealth system can improve care among primary care patients with SUDs, and patients using
the system can support one another in their recovery. Among clinicians, however, implementation requires figuring out how
information from the mHealth system will be used and making mHealth data available in the electronic health (eHealth) record.
In addition, paying for an mHealth system remains a challenge.
(J Med Internet Res 2018;20(1):e37)   doi:10.2196/jmir.8928
KEYWORDS
mobile health; mHealth; evidence-based practice; behavioral medicine
Introduction
The Use of mHealth in Primary Care
Despite the near ubiquity of mobile phones, little systematic
research has been conducted on the use or implementation of
mobile health (mHealth) technology in managing chronic health
conditions in primary care. Although primary care patients use
mHealth apps, their use is generally haphazard and self-selected
[1,2]. The mHealth apps available to the public vary greatly in
quality, and problems such as software bugs, poor design, and
limited technical support are common [3]. Perhaps not
surprisingly, given these problems, the majority of health-related
apps are used only once [4]. Primary care clinicians know very
little about the mHealth systems their patients are using, and
most clinicians receive no health-related information from
mHealth systems [1,5]. The literature contains numerous pilot
studies and descriptions of mHealth systems [6] but only a few
rigorous studies about the use of mHealth in primary care [5,7].
Implementation research studies in which primary care clinics
enroll cohorts of patients using the same mHealth system in an
orchestrated fashion are particularly lacking. Thus, the role
mHealth can play in the US primary care system remains largely
unknown [8].
mHealth Interventions for Addiction Treatment
Although hundreds of mobile phone apps for addiction treatment
are available commercially, most of these apps have not been
evaluated in the peer-reviewed literature [9]. The small number
of apps that have been evaluated constitute a growing body of
evidence supporting the effectiveness of mHealth in treating
addiction [10-13]. Most of this evidence relates to self-help
interventions [10,11,13] and to texting-based monitoring and
reminder systems [9,12]. Little evidence relates to
comprehensive mHealth systems for addiction, which have the
strongest theoretical base and the most long-lasting effects, or
to mHealth interventions for addiction integrated into patients’
recovery and health plans [9].
Barriers to the Integration of Behavioral Health in
Primary Care
In this paper, we report the results of an implementation research
trial funded by the National Institutes of Health–National
Institute on Drug Abuse. The trial aimed to integrate behavioral
health treatment into primary care. We focused on one aspect
of behavioral health—addiction—that presents considerable
barriers to integration, such as the inability to bill for services,
mental health stigma, and primary care physicians being
ill-prepared to treat behavioral health problems [14,15]. Primary
care operates under productivity guidelines that limit the time
clinicians can spend with patients, whereas addiction treatment
typically involves frequent counseling sessions. Medication is
crucial in primary care, but it has a comparatively short history
in addiction treatment [16]. Primary care focuses on chronic
conditions, such as diabetes and hypertension, and practitioners
expect that patients’ adherence to treatment will vary over time.
Behaviorial health has only recently begun to view addiction
as a chronic condition [16-18]. Lapses have often resulted in
discharge from treatment. Primary care treats patients
one-on-one, whereas behavioral health often organizes patients
into groups for treatment [19]. Financing models and
information technology (IT) infrastructure also differ greatly
between the two systems of care [17]. Finally, patients with
addictions often have elevated anxiety and present frustrating
behaviors to providers, such as frequently missing appointments
[20].
In this research, our premise was that mHealth could ease the
integration of addiction treatment into primary care. We
proposed to examine how implementing an evidence-based
mHealth system for addiction could be useful to both patients
and clinical staff in real-world primary care settings. The
mHealth system used in the study is named Seva, a Sanskrit
word meaning “selfless caring.” Its key components were
previously proven effective in carefully controlled patient-level
randomized clinical trials [21,22]. In a randomized clinical trial
conducted in patients with alcohol use disorder leaving 90-day
residential care, the intervention comprising the backbone of
Seva reduced risky drinking days by 57% [21] and increased
retention in treatment by 77% [23] compared with patients in
the control group.
Purpose of This Study
The study reported here sought answers to 3 broad research
questions:
1. How can Seva be implemented in primary care settings
efficiently and effectively?
2. To what extent do patients and staff accept and use Seva?
3. How does Seva affect clinical care for patients and staff?
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Methods
Study Design
Because the study tested both clinical and implementation
interventions, it is considered to be a hybrid type 2
effectiveness-implementation study [24]. Details of the study
protocol, the theoretical foundations of the implementation
strategy, and a description of Seva were published previously
[25]. This paper reports quantitative and observational results.
Selected qualitative results were reported separately [26].
We made Seva available to up to 100 patients at each of 3
federally qualified health centers (FQHCs) across the United
States of America. FQHCs are federally funded primary care
clinics that serve mainly low-income patients. As a condition
of funding, FQHCs must provide access to behavioral health
services. Thus, FQHCs are in the vanguard of clinics in the
United States trying to integrate behavioral health into primary
care. FQHCs also serve very vulnerable patients—many in
poverty and suffering from addiction. At each site, patients were
enrolled over a 12-month period. After enrollment, patients had
access to Seva for 12 months.
Because the focus of the study was implementation and not
patient outcomes per se, the study did not randomize patients.
Instead, clinicians were free to enroll any patients from their
substance-using populations whom they thought might benefit
from Seva based on their clinical judgment. We used the Reach,
Effectiveness, Adoption, Implementation, and Maintenance
(RE-AIM) framework to organize the evaluation [27]. The
RE-AIM framework is a predominant evaluation framework in
implementation research studies.
Ethics
The study protocol was approved by the Medical Sciences
Institutional Review Board at the University of
Wisconsin–Madison (2012-0937-CP020) and is registered at
ClinicalTrials.gov (NCT01963234).
Clinic Recruitment
Clinics were recruited in partnership with the National
Association of Community Health Centers. We recruited FQHCs
with established electronic health (eHealth) records to
understand how Seva relates to existing clinic technology. In
selecting sites, we aimed to achieve geographic reach, diversity
in patient populations, and differences in organizational
structures to better understand how environmental and structural
factors might affect implementation. From a pool of
approximately 1100 FQHCs nationally, we selected an FQHC
affiliated with the University of Wisconsin as a pilot site; a
relatively small, rural, freestanding FQHC with integrated
behavioral health services (including addiction treatment) as a
second site; and an urban FQHC that largely serves a minority
population as our third site.
Clinician and Patient Recruitment
A limited number of clinician subjects consented at each site.
These staff subjects worked with the research team to integrate
Seva into clinical workflows during the preimplementation
phase and subsequently identified, recruited, enrolled, and
trained patients to use Seva and monitored patients’ use of the
system.
Authorized clinicians identified potential subjects through the
electronic health record (EHR). On the basis of their clinical
judgment, clinicians were free to enroll patients from their
substance-using populations whom they thought might benefit
from Seva. The patients had to meet the following inclusion
criteria: (1) aged 18 years or older, (2) meet the criteria for
substance use disorder (SUD) as per the Severity of Dependence
Scale, (3) have no current psychotic disorder severe enough to
prevent participation, (4) have no acute medical problem
requiring immediate inpatient treatment, (5) are willing to use
Seva, and (6) could understand and sign a consent form in
English. If a patient was incarcerated during the study, his or
her participation was stopped. If he or she was still interested
in participating in the study when released from jail, the person
was able to rejoin the study. Patient participation was voluntary.
Patient subjects were excluded if (1) their condition warranted
inpatient detoxification until they were well enough to
participate and (2) they were unable to understand and complete
the informed consent. Couples were not recruited to the study
at the same time to avoid dyadic conflict.
During a clinic appointment, the clinician asked an eligible
patient if he or she was interested in learning more about the
study. If the patient was interested and gave permission, the
clinician notified the site coordinator that a patient was interested
in hearing about the project. In the privacy of a clinic exam
room or office, the site coordinator explained the study, its
benefits, and potential risks of participation. The site coordinator
also answered any questions the patient (subject) had. If the
patient was interested in participating, he or she was asked to
complete the informed consent.
The flow of patients through the study is shown in Figure 1.
Training Patients on Seva
The site coordinator trained participants in person. Participants
could download Seva if they had their own mobile phone. If
they did not, the site coordinator gave participants a phone and
basic instructions on how to use it. Then he or she explained
and showed participants how to use the different services of
Seva. Participants were encouraged to ask questions and were
given a toll-free number to call the Seva technical support line
if they had any questions. Each participant also received a user
guide that showed all Seva services and explained how to use
them with easy text and graphic instructions.
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Figure 1. Participant flowchart.
Clinic Rollout Process
Each site designated a change leader, a clinical leader who was
the point of contact with the implementation coach and
coordinated implementation activities; the site coordinator; and
a change team of 4 to 8 clinical and/or administrative staff
members who helped make the organizational changes that were
necessary to implement Seva. The coach made an initial site
visit during the 4-month period of implementation preparation
to create a welcoming environment for Seva. During this visit,
the coach conducted a walk-through exercise with the change
team members (an exercise in which employees experience
clinic processes as patients do); a workflow assessment using
flowcharting; and a technical assessment of data to be gathered
and procedures needed to conduct the study. Through this
preparation period, the coach worked with the change leader to
ensure that pretest data were collected, Seva was demonstrated
to clinical teams who might serve as referral sources, and
barriers to implementation were identified and rectified.
mHealth Intervention
Seva offered patients a discussion board used by the patients in
the study; interactive modules to teach problem-solving,
self-regulation, and other skills; tools for coping with cravings
and high-risk situations (eg, relaxation exercises, strategies from
cognitive behavioral therapy, links to local 12-step meetings);
and health tracking. For clinicians, Seva provided a Web portal
with a Clinician Report containing longitudinal information
generated by patients’ self-reported data about their substance
use and well-being (eg, sleep, depression).
Implementation Strategy
We created a detailed implementation plan tailored to each
clinic. The implementation strategy involved 4 phases at each
site, which were (1) initiate (bring key clinical staff together for
training), (2) prepare (assure a welcoming environment for
Seva), (3) improve (conduct rapid-cycle tests of ideas from the
previous stages), and (4) implement (use, monitor, and sustain
the technology). An organizational coach (a member of the
research team experienced in coaching) helped clinics implement
Seva, starting with an in-person planning and kick-off meeting.
This meeting was to be followed by monthly phone calls.
Implementation plans consisted of a list of scheduled activities,
such as when recruitment would start and end, when patients
would be trained to use Seva, and so on. The implementation
plans were informed by baseline assessments of readiness for
implementation, sustainability potential, and technology
acceptance from the perspective of clinic staff members who
worked on the implementation plan [28-30].
We expected that Seva would enable primary care physicians
to better manage addiction in their patients, much as they
manage chronic conditions such as diabetes and asthma, by
making information about a patient’s recovery readily available.
Physicians and other clinicians who referred a patient to
behavioral health could see through Seva how these referrals
worked out. Seva would also improve outcomes by making
support, information, and skills training available to patients
almost anywhere and anytime.
Outcomes
The measures used in this study are summarized in Table 1.
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Table 1. List of measures.
Data source(s)Domain and measure
Reach
EHRa, patient surveysNumber of Seva patients (eligible, enrolled)
Patient surveysCharacteristics of participating patients
Effectiveness
Patient surveysSubstance use
Patient surveysQoLb
Patient surveysHealth care utilization (hospitalizations, ERc visits, specialty addiction treatment)
Patient surveysHIV testing rates
Patient surveysHIV risk behaviors
Adoption
Clinic administrative dataCharacteristics of participating clinics
Seva server files, referral tracking logs maintained by
clinic staff
Use of Seva by staff (including referrals)
Seva server filesUse of Seva by patients
Implementation
Project tracking logs maintained by research teamStages of Implementation Completion
Observation and interviews of clinic staff; project admin-
istrative data
Implementation and operating costs
Maintenance
Patient surveys6-month follow-up on effectiveness measures
Seva server filesPatient use of Seva at 12 months
aEHR: electronic health record.
bQoL: quality of life.
cER: emergency room.
To assess Reach, we examined the characteristics of the
participating sites and the patients they serve. We examined
how many patients were eligible to use Seva in each clinic
versus how many enrolled in the study over the enrollment
period.
To assess Effectiveness, we considered patients’ substance use,
quality of life (QoL), health care utilization, human
immunodeficiency virus (HIV) risk behaviors, and HIV testing
rates through self-reported data collected in surveys administered
in person at baseline and by phone at 6 months. Risky drinking
days were the number of days in the past 30 days on which,
within a period of 2 hours, women consumed more than 3
standard drinks and men more than 4 standard drinks,
corresponding to the National Institute on Alcohol Abuse and
Alcoholism’s definition of binge drinking [31]. Illicit drug use
days were defined as the number of days in the past 30 days on
which participants used any illicit drug. QoL was measured
using the PROMIS Global Health Scale [32].
Effectiveness outcomes are reported for differences between
baseline and 6 months. To handle skew distributions,
nonparametric related sample tests (Wilcoxon signed rank tests
for continuous and ordinal variables and McNemar tests for
binary outcomes) were conducted. P values (2-tailed) and effect
sizes were reported.
We assessed Adoption at both the patient and clinic level. For
patients, we assessed weekly rates of Seva use, with use defined
as a patient accessing any part of Seva beyond the home page
during a given week in the 12-month period when patients’
phones and service plans were paid for. We defined clinician
use in two ways—by the number of log-ins by clinicians per
week to the website where Seva data were available and by the
number of referrals to Seva. We also tracked the total number
of Seva patients enrolled and whether medical providers (doctors
of medicine [MDs], residents, physician assistants [PAs], nurse
practitioners [NPs], and nurses or behavioral health providers)
referred patients to Seva. To assess Implementation, we used
the Stages of Implementation Completion model [33]. The stages
of implementation completion are (1) engagement; (2)
consideration of feasibility; (3) readiness planning; (4) staff
hired and trained; (5) fidelity monitoring processes in place; (6)
services and consultation begin; (7) ongoing services,
consultation, fidelity monitoring, and feedback; and (8)
competency. We planned to assess Maintenance in a follow-up
phone survey 6 months after each patient’s 12-month
intervention period ended, but this plan was abandoned, as
discussed below.
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Results
Reach
We selected an FQHC in Madison, WI, affiliated with the
University of Wisconsin-Madison as our pilot implementation
site; a relatively small, rural, freestanding FQHC with integrated
behavioral health services, including addiction treatment, in
Missoula, MT, was our second site; and an urban FQHC in the
Bronx, NY, that serves a largely minority population was our
third site (Table 2). In all 3 clinics, a total of 3226 patients were
deemed clinically appropriate to use Seva in the 12 months
corresponding to the implementation period. This number of
appropriate patients represents all patients with a SUD diagnostic
code in the EHR. With 268 patients enrolled, the intervention
reached approximately 8.31% (268/3226) of patients with
substance use issues at these 3 clinics. The reach of Seva to the
target population was limited by our ability to pay for phones
and data plans for a maximum of 100 patients per clinic. The
racial and ethnic composition of patients in the study departs
somewhat from those of US adults 18 or older estimated by the
Substance Abuse and Mental Health Services Administration
to meet the Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition (DSM-IV) criteria for alcohol dependence
and abuse, with study participants being 67.9% (182/268) white
versus 55% nationally; 25.0% (67/268) African American/Black
versus 16% nationally; 11.6% (31/268) Other versus 10%
nationally; and 14.2% (38/268) Hispanic/Latino versus 20%
nationally [34]. At least one clinic indicated more patients could
have been enrolled.
Effectiveness
Tables 3 and 4 show changes in patient outcomes reported from
baseline to 6 months. Of 268 enrolled patients, 207 (77.2%)
were included in this analysis. Effect sizes were calculated per
Cohen [35].
In the substance use domain, significant reductions were
observed for the number of risky drinking days (the primary
outcome in the clinical trial preceding this implementation
study), which declined by 44% [(0.7-1.25)/1.25] from baseline
to 6 months and illicit drug-use days, which declined by 34%
[(2.14-3.22)/3.22]. Two of the three abstinence outcomes also
showed significant improvements (any illicit drug use and/or
any drink or drug). Significant effects were found for two of
the three QoL scores (overall QoL and mental health). Table 3
also shows a significant reduction in hospitalizations and a trend
toward fewer emergency room (ER) visits. Table 4 shows an
increase in HIV screening rates. Change in the rates of HIV risk
behaviors (eg, condom use) and receiving other addiction
treatments appeared to be nonsignificant.
Post hoc analyses assessed the relationship between the extent
of Seva use and our study outcomes at 6 months. For each
outcome, we used linear or logistic regression, controlling for
the value of the outcome at baseline. System use was
operationalized as (1) the total number of calendar days during
the first 6 months on which individuals used Seva (going beyond
the main menu), and (2) the total number of Seva pages viewed
in the first 6 months (excluding the main menu). These system
use measures were natural log transformed to reduce skewness.
We found that participants who used Seva on more days in the
first 6 months showed a significant increase in alcohol
abstinence (P=.02), and participants who loaded more Seva
pages showed a significant increase in overall abstinence from
both alcohol and drugs (P=.01), as well as reduced HIV risk
behaviors (P=.02). We found no significant associations between
system use and risky drinking days, illicit drug use days, health
care utilization, or QoL.
Whereas Seva’s quantitative results show promise in helping
primary care patients remain abstinent, other important effects
can be best appreciated by directly observing how mHealth
affected patient care. An exchange on the Seva discussion board
in the Bronx (Site 3) illustrates how the system helped patients
support one another. Figure 2 shows an unedited excerpt of this
exchange—only names have been changed. The
exchange—which occurred over a 2-hour period beginning at
4:41 AM, well before the clinic was open—illustrates how
patients struggling with addiction can support one another, in
real time, outside the clinic, using mHealth. As the exchange
highlights, the network of patients in the Bronx even took to
referring to themselves as the “Seva family.”
Adoption
Mobile health apps generally have low levels of continued
use—approximately 80% are abandoned after only 2 weeks
[36]. In this context, all 3 sites showed high levels of sustained
patient use (Figure 3). At the start of the study, rates of patient
use—defined as accessing any part of Seva beyond the home
page during each week of the 12-month implementation
period—at the 3 sites ranged from 94% (90/96) to 99% (69/70).
Rates of use declined, but slowly, with rates at 12 months
ranging from 53% (41/78) to 60% (39/65) across the 3 sites,
which mirrors the patient retention rate of 57.6% at 8 months
in the randomized trial of an earlier iteration of Seva [21].
Clinician adoption of Seva was less robust than patient adoption
for two main reasons. At each clinic, clinicians worried about
being responsible for data available from Seva. For example,
clinicians were concerned that a patient might express suicidal
thoughts in a discussion post and they would miss it. To address
this concern, the clinical staff at each clinic wanted one staff
member to lead the implementation and operation of Seva for
the clinic. This job included monitoring patient Seva activity
for the clinic and alerting clinicians of significant changes in
patient status. At 2 of the 3 sites, members of the behavioral
health department led the implementation and operation of Seva.
At the other site, the director of innovation led implementation.
Not all FQHCs have such a position. At one of the sites, the
behavioral health provider who led the implementation of Seva
left the clinic near the end of the patient enrollment period.
Members of the research team increased their involvement at
the site to pick up the slack, but staff turnover remained a vexing
issue.
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Table 2. Baseline characteristics of participating clinics and patients.
Site 3 (Bronx, NY)Site 2 (Missoula, MT)Site 1 (Madison, WI)Characteristics
Clinic characteristics
Insurance of patients (%)
Insured
11.111.68.7Medicare
46.523.156.3Medicaid
28.919.418.5Private/other
13.545.916.5Not insured
EpiceClinicalworksEpiceHealtha records
Primary care and mental healthPrimary care, mental health,
and addiction
Primary care and mental healthServices offered
Level 3 (2014)Level 3 (2014)Level 3 (2011)PCMHb designation
Patient characteristics
10769611189Number of eligible SUDc patients
7110097Patients enrolled in Seva
Age (years)
22-6421-6621-64Range
42.66 (11.78)42.53 (10.24)41.61 (10.95)Mean (standard deviation)
Gender n, (%)
36 (51)40 (40)52 (54)Female
Drug of choice, n (%)
27 (38)44 (44)34 (35)Alcohol
8 (11)14 (14)31 (32)Opiates
11 (16)3 (3)9 (9)Crack cocaine
16 (23)4 (4)1 (1)Marijuana
1 (1)15 (15)0 (0)Methamphetamine
8 (11)20 (20)22 (23)Multiple drugs
Ethnicity n (%)
35 (49)2 (2)1 (1)Hispanic/Latino
Race, n (%) d
24 (33)90 (90)68 (70)White
35 (50)2 (2)30 (31)African American/Black
1 (2)8 (8)4 (4)American Indian or Alaskan Native
0 (0)1 (1)0 (0)Asian or Pacific Islander
15 (21)2 (2)0 (0)Other
aeHealth: electronic health.
bPCMH: patient-centered medical home. Three levels of recognition exist, based on practice sites meeting six standards. Level 3 clinics have the best
adherence to the standards.
cSUD: substance use disorder.
dPercentages do not add to 100 because patients could select more than one race.
J Med Internet Res 2018 | vol. 20 | iss. 1 | e37 | p.7http://www.jmir.org/2018/1/e37/
(page number not for citation purposes)
Quanbeck et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Table 3. Effectiveness results, continuous patient outcomes
Effect size db,cZa,b (P value)6 monthsBaselineSample sizeMeasures
Mean (SD)Mean (SD)N
Substance use in last 30 days
-0.228-2.304 (.02)1.67 (4.69)2.53 (6.01)207Any drinking days
-0.199-2.008 (.4)0.70 (2.58)1.25 (3.78)207Risky drinking daysd
-0.248-2.499 (.01)2.14 (6.55)3.22 (7.57)206Illicit drug-use days
QoL e
0.3703.653 (<.001)30.03 (7.11)28.47 (6.46)202Overall QoL
0.1671.682 (.09)13.48 (3.11)13.20 (3.01)206Physical subscale QoL
0.3933.892 (<.001)10.77 (3.50)9.75 (2.99)204Mental subscale QoL
Health care utilization in last 6 months
-0.335-3.357 (.001)0.22 (0.65)0.43 (1.03)207No. of hospitalizationsd
-0.189-1.911 (.06)0.75 (1.31)1.10 (2.79)207No. of ERf visitsd
aZ, provided in the Wilcoxon sign test, is the standard normal distributed Z-value used to test the significance between outcomes reported at two time
points (eg, pretest vs 6 months).
bFor Z and d values, negatives mean decreases and positives mean increases in values from baseline to 6 months.
cCalculated from effect size d. On the basis of Cohen (1988) effect size, small: d=0.2, medium: d=0.5, large: d=0.8.
dRisky drinking days, hospitalizations, and ER visits: Those who reported no such events were coded with zero in the number of days of these events.
eQoL: quality of life.
fER: emergency room.
Table 4. Effectiveness results, dichotomized patient outcomes
Odds ratioaChi-square (P value)6 monthsBaselineSample sizeMeasures
n (%)n (%)N
Substance use in last 30 days
0.5523.2 (.07)51 (24.6)64 (30.9)207Any drink (Yes)
0.27014.38 (<.001)36 (17.5)63 (30.6)206Illicit drug use (Yes)
0.34912.57 (<.001)69 (33.5)97 (47.1)206Any drink or drug (Yes)
Health care utilization in last 6 months
0.6941.639 (.20)78 (37.7)89 (43)207Currently receive other addiction treatments (Yes)
HIV in last 6 months
0.6671.818 (.18)65 (31.4)76 (36.7)207HIV risky behavior (Yes)
—b33.03 (<.001)116 (56.3)81 (39.3)206HIV testing (Yes)
aNumbers lower than 1 mean reductions of the events from baseline to 6 months.
bThe odds ratio for this variable cannot be calculated because patients’ HIV testing status was considered current at 6 months if they had been tested at
baseline; that is, there were zero patients considered tested at pretest and not tested at 6 months.
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Figure 2. Exchange among Seva patients in the Bronx.
A second unexpected development affected clinician adoption:
We never succeeded in incorporating Seva data into the EHR
at each clinic. The interoperability of EHRs is a widely
recognized problem. In fact, the same system (eg, Epic Systems,
developed by Epic Systems Corporation) may function very
differently at one clinic versus another. The technical challenge
in getting Seva data into the EHR of 3 health systems proved
insurmountable in the context of this implementation research
project. Instead, clinicians who wanted to review Seva data had
to go to a website outside the EHR.
At each site, the leaders of Seva implementation and operation
logged into Seva regularly during the 24 months of enrollment
and implementation. At Site 1, 2 other staff clinicians besides
the clinic Seva leader from behavioral health were most involved
with Seva. The 3 clinicians at Site 1—one primary care
physician and 2 behavioral health staff members—logged in an
average of 0.6, 0.5, and 1.0 days per week. The Seva clinic
leaders at Sites 2 and 3 were also the main users of Seva. The
director of innovation at Site 2 logged in an average of 1.7 days
per week, and a member of the behavioral health group at Site
3 logged in an average of 4.1 days per week. At two sites,
behavioral health providers made most referrals of patients to
Seva: 92% (89/97) of referrals at Site 1 and 76% (54/71) at Site
3. At Site 2, on the other hand, where we observed especially
strong leadership and operational support for integrating
behavioral with medical health, medical providers made 92%
(92/100) of referrals (see Table 5).
Implementation
Table 5 also shows the percent of implementation goals and
milestones completed. At the first two sites, we largely executed
our implementation plan successfully in the preimplementation
and implementation stages. At the third site, we struggled during
preimplementation, primarily because of delays in getting the
institutional review board’s (IRB) approval, which cost 6
additional months. Cost, which was specified in the protocol as
another element of implementation, is reported below.
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Figure 3. Percentage of patients who logged onto Seva at least once per study week. Patients were excluded from analysis at the point when they were
removed from the study (eg, if they lost their phone, died, or were incarcerated).
Table 5. Adoption and implementation outcomes.
Site 3
(Bronx, NY)
Site 2
(Missoula, MT)
Site 1
(Madison, WI)
Measures
7110097Total number of Seva patients
277470Total number of primary care clinical staff at sitea
17 (24)92 (92)8 (8)Number of patients referred to Seva by primary care clinical staff out of total number of
Seva patients, n (%)
11810Total number of behavioral health providers at siteb
54 (76)8 (8)89 (92)Number of patients referred to Seva by behavioral health providers out of total number of
Seva patients, n (%)
Time to completion of project phases (months)
181212Preimplementation (12 months planned)
161318Implementation (12 months planned)
142Maintenance (12 months planned)
Number and percentage of implementation goals and milestones completed, n (%)
12 (100)12 (100)12 (100)Preimplementation (% of monthly implementation plan milestones reached)
71 (71)100 (100)97 (97)Implementation (% of 100 patient enrollment goal at each site)
1 (8)4 (33)2 (17)Maintenance (% of 12 monthly coaching follow up calls completed)
aClinical staff members were physicians, residents, physician assistants, nurse practitioners, registered nurses, licensed practical nurses, and medical
assistants.
bBehavioral health providers were licensed medical social workers, licensed mental health counselors, licensed clinical social workers, doctorate-level
psychologists, and physicians.
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Table 6. Cost analysis (US $).
Site 3 (Bronx, NY)Site 2 (Missoula, MT)Site 1 (Madison, WI)Type of costs
83,177117,150113,636Operating costs (patient and clinic)
28,12123,3459948Implementation costs (clinic)
111,298140,495123,584Total costs for clinic
156814051274Cost/patient
Our implementation plans and their execution arose from
baseline assessments of readiness for implementation,
sustainability potential, and technology acceptance by clinic
staff members who worked on the implementation plan, as well
as the information that researchers gained from directly
interacting with clinic staff. The plans for implementation
involved using an organizational coach to help clinics through
the 4 phases (initiate, prepare, improve, and implement), using
an initial in-person visit and then monthly phone calls between
the coach and the clinic change team. Although the
organizational coach was heavily involved in the first two
phases, another member of the research team who was most
familiar with operating Seva became the primary contact for
the clinics starting with the third phase. This researcher
monitored the Seva discussion groups and gave hands-on,
practical advice in response to questions from clinicians. Instead
of having monthly coaching calls, clinician-researcher contact
consisted mostly of short, frequent, ad hoc phone and email
communications between the main clinician users and the
research team’s site coordinator in response to specific patient
issues and technical questions. These were the types of problems
clinics wanted help in solving, rather than helping make
organizational change, which was the primary type of help
offered by the coach. Thus, we adapted our implementation
plan at each site to remove monthly coaching calls during the
implementation phase and instead focused on the enrollment of
patients as our primary implementation goal.
Maintenance
Maintenance, defined as continued use of Seva after the 12
months during which patient phones and data plans were paid
for, was low at all 3 sites. Patients were allowed to keep their
phones and could continue accessing Seva by using Wi-Fi or
paying for service themselves with a new phone number.
Although we did not track whether patients paid for new data
plans independently, we did track Seva use after the 12 months
of paid use. Use after 12 months declined gradually to zero once
the last recruited patient reached the end of the 12-month period
of paid phone use. The decline in use limited our ability to
collect follow-up patient surveys and led us to abandon our
attempts to collect the phone survey we planned to collect 6
months after each patient’s 12-month intervention period to
gauge maintenance. The decline in clinician use of Seva
mirrored patient decline. That is, as fewer patients used the
system, or if only a few later-enrolled patients were using it,
clinicians logged in less because Seva had little patient activity
for them to see.
Sites did not continue to use Seva after the study for at least
two reasons. First, we could not resolve issues related to
transitioning from a research study to ongoing use of an mHealth
system. In particular, establishing procedures for consenting
patients who wanted to use their own phones to access Seva
outside the research protocol, and commingling these patients
with patients from the research study, proved challenging.
Second, the National Institute of Health grant funding ended,
and none of the 3 clinics made arrangements to pay for mobile
phones and data plans afterwards. Offering Seva only to patients
who can cover their own mobile phone costs could have been
a condition of eligibility, but this choice would have shifted the
cost to patients and restricted access for low-income patients.
It may also have reduced patients’ motivation to use the system,
because patients reported that receiving a mobile phone was a
strong incentive to use Seva.
Without ongoing funding for patients to use the system, use of
Seva declined significantly and patients ultimately became
unreachable to the research staff (note that patient surveys were
administered over the phone, using the number associated with
the patient’s mobile phone). This led us to abandon our attempts
to collect the phone survey we planned to collect 6 months after
each patient’s 12-month intervention period to gauge
maintenance.
Cost
This analysis addresses cost from the perspective of an FQHC
clinic administrator—a comprehensive economic analysis of
the study will be reported separately. This analysis includes
operating costs (eg, mobile phones, data plans, clinician time
for monitoring Seva use, information technology [IT] staff time)
and the costs of executing the implementation strategy (eg, site
visits, coaching calls). Costs were tracked for 36 months across
each project phase (preimplementation, implementation, and
maintenance). Costs are broken down as follows: system
operating costs; implementation costs per clinic; and overall
cost per patient and per clinic (see Table 6). All costs are given
in US dollars. Operating costs per patient were estimated at US
$1185, which covers US $200 for a mobile phone; US $720 for
a voice and data plan (US $60/month x 12 months); US $135
in clinical staff time for patient identification, recruitment, and
training (based on observation and interviews with staff—this
2-stage process took an average of 1.5 hours per patient x US
$90/hour); and US $130 in staff time for monitoring patients’
use of Seva (based on server logs, clinical and research staff
spent 0.12 hours per patient per month monitoring patients; 0.12
hours per patient x 12 months x US $90/hour). We conducted
interviews with IT staff members to derive estimates of system
operating costs of US $8,000/per clinic over 36 months, which
covers costs such as technical support for users, server hosting,
and software updates to the system. Implementation costs were
estimated at US $10,350 per clinic, which includes US $8,100
for coaching time and expenses associated with site visits (3
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visits per clinic at US $500/day, including travel costs of US
$1200 per visit) and US $2250 for monthly follow up via email
and phone (36 hours x US $62.50/hour).
Total cost per clinic averaged approximately US $124,000 across
the 3 clinics; cost per patient averaged approximately US $1,400.
For comparison, the average cost for an episode of outpatient
addiction treatment among 21 addiction treatment programs
surveyed in 2008 (the year with the most recent available cost
data) was US $2325 [37].
Discussion
Principal Findings
To summarize our findings related to the three research
questions that were the focus of the study:
RQ1: How can Seva be implemented in primary care
settings efficiently and effectively?
The study offers the following 4 lessons about implementing
an mHealth system in primary care:
First, plan and have a budget for working extensively with clinic
IT staff to integrate mHealth data into the EHR. This very
challenging task is essential for integrating mHealth into primary
care because it makes the mHealth data part of rather than
separate from the data clinicians expect to see as they treat
patients. Second, work with clinic staff to figure out how the
mHealth system will fit into the clinic’s existing workflow. All
3 clinics in this study chose to appoint one clinician to monitor
Seva data and alert fellow clinicians as needed about important
changes in a patient’s recovery. Wider and deeper integration
would result from each clinician routinely monitoring data from
the mHealth system for his or her patients, just as he or she
monitors data related to other chronic conditions such as
diabetes. This level of involvement may be unrealistic, however,
given the time pressures on primary care staff, and assigning
routine monitoring to other clinical staff has been done
effectively in other studies we have conducted [38,39]. Third,
ensure that the questions clinical staff members have as they
operate the mHealth system can get rapid responses from the
mHealth developers. Most questions clinicians had in this study
were day-to-day operational issues (eg, how to enter a new
patient into the system) that were ideally addressed in the
moment they occurred by quickly calling the research team.
Fourth, to assure sustained use, address cost. Two of the 3 clinics
wanted to maintain using Seva based on patient and clinician
feedback and, at one site, cost savings from reduced hospital
admissions and ER visits. This last clinic used the cost savings
to make a case to an insurer to pay for Seva, a process still under
way at this writing.
RQ2: To what extent do patients and staff accept and
use Seva?
Patient use was exceptionally high compared with continued
use of most mHealth apps, although patient use declined steeply
after funding for the phones and data plans ended. Clinician use
was low compared with patient use because, as stated above,
clinicians worried about being responsible for data from Seva
and they had to view Seva data in a separate website rather than
in the EHR. Of the two aspects of integration we examined—the
integration of behavioral health into primary care, and the
integration of mHealth into the treatment of addiction in primary
care—the second was more successful than the first. Although
the treatment of patients suffering from addiction and the use
of Seva remained mainly the province of behavioral health
providers in this study, the integration of mHealth into addiction
treatment was successful if judged by the high levels of patient
use.
RQ3: How does Seva affect clinical care for patients
and staff?
This study showed the potential of patient peer support in
encouraging treatment adherence. Patient peer support is unusual
in primary care. It is also a type of care that does not add to,
and may reduce, clinician burden. Clinicians who used Seva
were generally enthusiastic about it, as demonstrated by 2 clinics
wanting to continue using the system after grant funding ended,
even though these intentions have thus far gone unfulfilled. The
number of clinicians involved, though, is too small to warrant
generalizations.
Comparisons With Prior Work
This study—which involved 3 unaffiliated primary care clinics
enrolling nearly 300 patients in the same mHealth system—is
the most comprehensive implementation research trial focused
on the use of mHealth in primary care yet conducted in the US
health care system. Implementation research on mHealth has
been focused almost entirely on developing countries in Africa,
where mHealth is usually used as a replacement for standard
health care and operates independently of any health care system
[40].
Prior studies focused on providing addiction treatment to
primary care patients have also been rare; we found only 2
clinical trials for primary care SUD interventions [41,42].
Neither of these trials used mHealth. Both addressed illicit drug
use and prescription drug abuse rather than AUD and neither
had an effect compared with the control group.
We observed significant reductions in drinking and substance
use among patients using Seva. These are promising reductions
compared with other outpatient AUD treatments. For example,
Project MATCH showed that psychosocial treatments for
alcoholism are not particularly effective [43], although more
recent studies of cognitive-behavioral therapy for SUDs have
demonstrated efficacy [44]. A Cochrane review of the
effectiveness of naltrexone, a commonly administered
medication for AUD, found a decreased risk of heavy drinking
by 17% compared with the placebo group and a decrease in the
number of drinking days of about 4% [45]. 
Granted, this study was an implementation research trial not
specifically designed to retest the effectiveness of Seva. A
rigorously designed randomized controlled trial would be
required to definitively demonstrate the effectiveness of Seva
within a substance-using primary care population.
Limitations
The study has some limitations. (1) The primary outcome, risky
drinking days, is a self-reported measure. (2) Selection bias
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could have affected which patients participated in the study.
Clinicians were advised to enroll any eligible patients they
thought might benefit from Seva, based on their clinical
judgment. It was not possible for us to tell if this led clinicians
to favor some patients over others (eg, those with more
education). (3) We could not retrieve racial and ethnic data for
SUD patients who were eligible to participate in the study but
were not enrolled, and we did not collect data about education
and socioeconomic status on Seva patient surveys, limiting our
understanding of the representativeness of the patient sample.
(4) We lost an opportunity to learn about sustainability from
the patient’s perspective because we could not reach patients
for the survey we planned to collect 6 months after each patient’s
12-month intervention period. (5) The study would be hard to
replicate because it reports on a mobile phone app that, like
almost all such apps, changes over time rather than remaining
stable. For example, since the start of this study, the app has
been rebuilt to update it to current accessibility and security
standards, add features (My Motivation), improve features (the
automatic tailoring of feedback in response to weekly surveys),
and add content for opioid addiction.
Challenges
The current findings suggest that mHealth faces several
formidable challenges to widespread implementation. The first
is integrating mHealth with EHRs (eg, Epic Systems), described
above. Clinicians in this study had to view Seva data by going
to a website outside the EHR, requiring already overburdened
clinicians to make extra mouse-clicks. In addition, logistical
and patient privacy concerns limited our ability to use EHR data
for evaluation purposes. For example, we could not obtain
participants’ attendance at primary care visits, which we planned
to include in the health care utilization analyses. The poor
interoperability and accessibility of EHRs are likely to generalize
to other researchers and mHealth developers, making research
challenging to conduct and limiting the usefulness of mHealth
systems for clinicians.
Another key challenge relates to the difficulty of enrolling
patients with SUDs. Clinics reported that it often took multiple
follow-up calls to get patients into the clinic to get informed
consent and conduct training, even though patients were often
excited about getting a mobile phone. The effort required to
enroll patients might have dampened enthusiasm for enrollment
beyond the first 100 patients that the budget provided for.
FQHCs are required by law to provide behavioral health
services. We do not know how Seva might function in a primary
care clinic without designated behavioral health staff. Although
Seva was somewhat integrated into behavioral health, it did not
deeply penetrate physicians' treatment of patients, as reported
previously about Site 1 [26] and observed in Sites 2 and 3,
perhaps reflecting the deep divides between primary care and
behavioral health mentioned in the Introduction [15].
Finally, our experience has revealed several fundamental
questions about the role of mHealth in primary care: Is the value
of patient peer support for behavioral health sufficient to make
the costs of embedding an mHealth system such as Seva into a
clinic’s operations worthwhile? Might it instead suffice for
patients to use mHealth systems on their own, based upon the
recommendation of primary care clinicians? If integrating
mHealth into clinic systems is deemed worthwhile, who bears
the costs? Certain costs, such as those for mobile phones and
data plans, could be borne by patients, some of whom already
pay for phones and data plans out of pocket. In this study, patient
use of Seva and survey follow-up rates dropped significantly
when research funding stopped paying for data plans. Yet, these
costs account for only about half the total cost of the system,
and lower-income patients often have pay-as-you-go data plans
that may not work with the data requirements of an mHealth
system such as Seva. Volunteer peer mentors could potentially
act as monitors, as clinicians and researchers did in this project,
thereby reducing the cost to clinics. Indeed, similar volunteer
roles are essential to the Alcoholics Anonymous model (eg,
“sponsors”).
Conclusions
mHealth has the potential to transform health care, and given
the enormous cost of health care, we need to make effective use
of every available resource. In contrast to the seemingly
inexorable rise in health care costs over time, the cost of
technology tends to decrease in accordance with Moore’s Law,
which posits that computing capability roughly doubles every
2 years. Our experience illustrates that mHealth can engage
patients suffering from addiction in ways that benefit patients
without adding substantial burden on health care providers.
Although challenges remain, thoughtful deployment of mHealth
could improve the treatment of addiction in primary care and
might also improve the treatment of other chronic conditions
that have prominent behavioral components (eg, diabetes). In
so doing, mHealth could transcend the physically local and
professionally controlled systems that characterize the US health
care system.
 
Acknowledgments
This research was funded by the National Institute on Drug Abuse grant number R01-DA034279. The funder had no role in any
aspect of the development, conduct, analysis, or reporting of the study. The authors wish to thank the dedicated clinicians and
staff members at the 3 clinics where the study was conducted, in particular, Chantelle Thomas from Access Community Health
Center in Madison, WI; Virna Little, Victoria Ward, and Tom McCarry from the Institute for Family Health, Center for Counseling,
at Walton, Bronx, NY; and Mary Jane Nealon from Partnership Health Center in Missoula, MT. The project could not have
succeeded without their dedication and support. We also thank Judith Ganch, Joseph Glass, Andrew Isham, Adam Maus, Helene
McDowell, Klaren Pe-Romashko, and Victoria Ward for their important contributions to the project.
J Med Internet Res 2018 | vol. 20 | iss. 1 | e37 | p.13http://www.jmir.org/2018/1/e37/
(page number not for citation purposes)
Quanbeck et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Conflicts of Interest
Authors DG, FM, RJ, and AQ have a shareholder interest in CHESS Mobile Health, a public benefit corporation that disseminates
technology to the specialty addiction treatment system. CHESS Mobile Health did not develop Seva. The relationship between
the authors and CHESS Mobile Health is managed by the authors and the University of Wisconsin–Madison’s Conflict of Interest
Committee. LM is affiliated with HealthSim, LLC—a small business that developed the Web-based Therapeutic Education System
(TES). The relationship is extensively managed by LM and her academic institution. All other authors declare that they have no
competing interests.
References
1. Bauer AM, Rue T, Keppel GA, Cole AM, Baldwin L, Katon W. Use of mobile health (mHealth) tools by primary care
patients in the WWAMI region Practice and Research Network (WPRN). J Am Board Fam Med 2014;27(6):780-788 [FREE
Full text] [doi: 10.3122/jabfm.2014.06.140108] [Medline: 25381075]
2. Singh K, Drouin K, Newmark LP, Lee J, Faxvaag A, Rozenblum R, et al. Many mobile health apps target high-need,
high-cost populations, but gaps remain. Health Aff (Millwood) 2016 Dec 01;35(12):2310-2318. [doi:
10.1377/hlthaff.2016.0578] [Medline: 27920321]
3. Wicks P, Chiauzzi E. 'Trust but verify'—five approaches to ensure safe medical apps. BMC Med 2015;13:205 [FREE Full
text] [doi: 10.1186/s12916-015-0451-z] [Medline: 26404791]
4. Ades J. Mpulsemobile. Healthcare apps: the good, the bad, the ugly URL: https://mpulsemobile.com/2016/07/
good-bad-ugly-healthcare-apps/ [WebCite Cache ID 6t6bOSphh]
5. Torous J, Chan S, Luo J. Psychnews.psychiatryonline. 2016. Are your patients using 'digital supplements'? URL: http:/
/psychnews.psychiatryonline.org/doi/full/10.1176%2Fappi.pn.2016.11b16 [WebCite Cache ID 6t6c6W2Kp]
6. Fiordelli M, Diviani N, Schulz PJ. Mapping mHealth research: a decade of evolution. J Med Internet Res 2013;15(5):e95
[FREE Full text] [doi: 10.2196/jmir.2430] [Medline: 23697600]
7. Donker T, Petrie K, Proudfoot J, Clarke J, Birch M, Christensen H. Smartphones for smarter delivery of mental health
programs: a systematic review. J Med Internet Res 2013;15(11):e247 [FREE Full text] [doi: 10.2196/jmir.2791] [Medline:
24240579]
8. Steinhubl SR, Muse ED, Topol EJ. Can mobile health technologies transform health care? J Am Med Assoc 2013 Dec
11;310(22):2395-2396. [doi: 10.1001/jama.2013.281078] [Medline: 24158428]
9. Quanbeck A, Chih MY, Isham A, Gustafson D. Mobile delivery of treatment for alcohol use disorders: a review of the
literature. Alcohol Res 2014;36(1):111-122 [FREE Full text] [Medline: 26259005]
10. Riper H, Spek V, Boon B, Conijn B, Kramer J, Martin-Abello K, et al. Effectiveness of E-self-help interventions for curbing
adult problem drinking: a meta-analysis. J Med Internet Res 2011;13(2):e42 [FREE Full text] [doi: 10.2196/jmir.1691]
[Medline: 21719411]
11. Campbell W, Hester RK, Lenberg KL, Delaney HD. Overcoming Addictions, a web-based application, and SMART
Recovery, an online and in-person mutual help group for Problem drinkers, part 2: six-month outcomes of a randomized
controlled trial and qualitative feedback from participants. J Med Internet Res 2016 Oct 04;18(10):e262 [FREE Full text]
[doi: 10.2196/jmir.5508] [Medline: 27701064]
12. Berrouiguet S, Baca-García E, Brandt S, Walter M, Courtet P. Fundamentals for future mobile-health (mHealth): a systematic
review of mobile phone and web-Based text messaging in mental health. J Med Internet Res 2016 Jun 10;18(6):e135 [FREE
Full text] [doi: 10.2196/jmir.5066] [Medline: 27287668]
13. World Health Organization. E-health technologies and substance abuse URL: http://www.who.int/substance_abuse/activities/
ehealth/en/ [WebCite Cache ID 6vHzMRZzq]
14. Klein S, Hostetter M. The Commonwealth Fund. 2014. In focus: integrating behavioral health and primary care URL: http:/
/www.commonwealthfund.org/publications/newsletters/quality-matters/2014/august-september/in-focus [WebCite Cache
ID 6t6ceiR8u]
15. Awoyinka L, Gustafson D, Johnson R. Using technology to integrate behavioral health into primary care. In: Marsch L ,
Lord S , Dallery J , editors. Behavioral Healthcare and Technology: Using Science-Based Innovations to Transform Practice.
New York: Oxford University Press; 2014.
16. Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract 2007 Dec;4(1):45-55 [FREE Full
text] [Medline: 18292710]
17. Pating DR, Miller MM, Goplerud E, Martin J, Ziedonis DM. New systems of care for substance use disorders: treatment,
finance, and technology under health care reform. Psychiatr Clin North Am 2012 Jun;35(2):327-356. [doi:
10.1016/j.psc.2012.03.004] [Medline: 22640759]
18. Capoccia VA, Grazier KL, Toal C, Ford 2nd JH, Gustafson DH. Massachusetts's experience suggests coverage alone is
insufficient to increase addiction disorders treatment. Health Aff (Millwood) 2012 May;31(5):1000-1008 [FREE Full text]
[doi: 10.1377/hlthaff.2011.0326] [Medline: 22566439]
19. DeRubeis RJ, Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental
disorders. J Consult Clin Psychol 1998 Feb;66(1):37-52. [Medline: 9489261]
J Med Internet Res 2018 | vol. 20 | iss. 1 | e37 | p.14http://www.jmir.org/2018/1/e37/
(page number not for citation purposes)
Quanbeck et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
20. Molfenter T. Reducing appointment no-shows: going from theory to practice. Subst Use Misuse 2013 Jun;48(9):743-749
[FREE Full text] [doi: 10.3109/10826084.2013.787098] [Medline: 23607670]
21. Gustafson DH, McTavish FM, Chih M, Atwood AK, Johnson RA, Boyle MG, et al. A smartphone application to support
recovery from alcoholism: a randomized clinical trial. J Am Med Assoc Psychiatry 2014 May;71(5):566-572 [FREE Full
text] [doi: 10.1001/jamapsychiatry.2013.4642] [Medline: 24671165]
22. Bickel WK, Marsch LA, Buchhalter AR, Badger GJ. Computerized behavior therapy for opioid-dependent outpatients: a
randomized controlled trial. Exp Clin Psychopharmacol 2008 Apr;16(2):132-143 [FREE Full text] [doi:
10.1037/1064-1297.16.2.132] [Medline: 18489017]
23. Glass JE, McKay JR, Gustafson DH, Kornfield R, Rathouz PJ, McTavish FM, et al. Treatment seeking as a mechanism of
change in a randomized controlled trial of a mobile health intervention to support recovery from alcohol use disorders. J
Subst Abuse Treat 2017 Jun;77:57-66. [doi: 10.1016/j.jsat.2017.03.011] [Medline: 28476273]
24. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements
of clinical effectiveness and implementation research to enhance public health impact. Med Care 2012 Mar;50(3):217-226
[FREE Full text] [doi: 10.1097/MLR.0b013e3182408812] [Medline: 22310560]
25. Quanbeck AR, Gustafson DH, Marsch LA, McTavish F, Brown RT, Mares M, et al. Integrating addiction treatment into
primary care using mobile health technology: protocol for an implementation research study. Implement Sci 2014 May
29;9:65 [FREE Full text] [doi: 10.1186/1748-5908-9-65] [Medline: 24884976]
26. Mares M, Gustafson DH, Glass JE, Quanbeck A, McDowell H, McTavish F, et al. Implementing an mHealth system for
substance use disorders in primary care: a mixed methods study of clinicians' initial expectations and first year experiences.
BMC Med Inform Decis Mak 2016 Sep 29;16(1):126 [FREE Full text] [doi: 10.1186/s12911-016-0365-5] [Medline:
27687632]
27. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM
framework. Am J Public Health 1999 Sep;89(9):1322-1327. [Medline: 10474547]
28. Wen K, Gustafson DH, Hawkins RP, Brennan PF, Dinauer S, Johnson PR, et al. Developing and validating a model to
predict the success of an IHCS implementation: the Readiness for Implementation Model. J Am Med Inform Assoc
2010;17(6):707-713 [FREE Full text] [doi: 10.1136/jamia.2010.005546] [Medline: 20962135]
29. Maher L, Gustafson D, Evans A. Webarchive.nationalarchives.gov.uk. Leicester, England: British National Health Service
Modernization Agency; 2004. Sustainability, model and guide URL: http://webarchive.nationalarchives.gov.uk/
20160805122935/http://www.nhsiq.nhs.uk/media/2757778/nhs_sustainability_model_-_february_2010_1_.pdf [accessed
2017-08-30] [WebCite Cache ID 6t6wxXbsT]
30. Legris P, Ingham J, Collerette P. Why do people use information technology? A critical review of the technology acceptance
model. Inf Manage 2003 Jan;40(3):191-204. [doi: 10.1016/S0378-7206(01)00143-4]
31. Cranford JA, McCabe SE, Boyd CJ. A new measure of binge drinking: prevalence and correlates in a probability sample
of undergraduates. Alcohol Clin Exp Res 2006 Nov;30(11):1896-1905 [FREE Full text] [doi:
10.1111/j.1530-0277.2006.00234.x] [Medline: 17067355]
32. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from
the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res 2009
Sep;18(7):873-880 [FREE Full text] [doi: 10.1007/s11136-009-9496-9] [Medline: 19543809]
33. Chamberlain P, Brown CH, Saldana L. Observational measure of implementation progress in community based settings:
the Stages of Implementation Completion (SIC). Implement Sci 2011 Oct 06;6:116 [FREE Full text] [doi:
10.1186/1748-5908-6-116] [Medline: 21974914]
34. Center for Behavioral Health Statistics and Quality. Substance Abuse and Mental Health Services Administration. Rockville,
MD: Substance Abuse and Mental Health Services Administration; 2016. 2015 National Survey on Drug Use and Health:
Detailed Tables URL: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/
NSDUH-DetTabs-2015.pdf [WebCite Cache ID 6wi6oMKUd]
35. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
36. Baldwin JL, Singh H, Sittig DF, Giardina TD. Patient portals and health apps: pitfalls, promises, and what one might learn
from the other. Healthc (Amst) 2016 Oct 3;5(3):81-85 [FREE Full text] [doi: 10.1016/j.hjdsi.2016.08.004] [Medline:
27720139]
37. French MT, Popovici I, Tapsell L. The economic costs of substance abuse treatment: updated estimates and cost bands for
program assessment and reimbursement. J Subst Abuse Treat 2008 Dec;35(4):462-469 [FREE Full text] [doi:
10.1016/j.jsat.2007.12.008] [Medline: 18294803]
38. DuBenske LL, Gustafson DH, Shaw BR, Cleary JF. Web-based cancer communication and decision making systems:
connecting patients, caregivers, and clinicians for improved health outcomes. Med Decis Making 2010;30(6):732-744
[FREE Full text] [doi: 10.1177/0272989X10386382] [Medline: 21041539]
39. Dubenske LL, Chih M, Dinauer S, Gustafson DH, Cleary JF. Development and implementation of a clinician reporting
system for advanced stage cancer: initial lessons learned. J Am Med Inform Assoc 2008;15(5):679-686 [FREE Full text]
[doi: 10.1197/jamia.M2532] [Medline: 18579837]
J Med Internet Res 2018 | vol. 20 | iss. 1 | e37 | p.15http://www.jmir.org/2018/1/e37/
(page number not for citation purposes)
Quanbeck et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
40. Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, what does not work and why of
implementation of mobile health (mHealth) projects in Africa. BMC Public Health 2014;14:188 [FREE Full text] [doi:
10.1186/1471-2458-14-188] [Medline: 24555733]
41. Saitz R, Palfai TP, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travaglini CA, et al. Screening and brief intervention for
drug use in primary care: the ASPIRE randomized clinical trial. J Am Med Assoc 2014 Aug 06;312(5):502-513 [FREE
Full text] [doi: 10.1001/jama.2014.7862] [Medline: 25096690]
42. Roy-Byrne P, Bumgardner K, Krupski A, Dunn C, Ries R, Donovan D, et al. Brief intervention for problem drug use in
safety-net primary care settings: a randomized clinical trial. J Am Med Assoc 2014 Aug 06;312(5):492-501 [FREE Full
text] [doi: 10.1001/jama.2014.7860] [Medline: 25096689]
43. Cutler RB, Fishbain DA. Are alcoholism treatments effective? The Project MATCH data. BMC Public Health 2005 Jul
14;5:75 [FREE Full text] [doi: 10.1186/1471-2458-5-75] [Medline: 16018798]
44. McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am
2010 Sep;33(3):511-525 [FREE Full text] [doi: 10.1016/j.psc.2010.04.012] [Medline: 20599130]
45. Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence.
Cochrane Database Syst Rev 2010 Dec 08(12):CD001867. [doi: 10.1002/14651858.CD001867.pub2] [Medline: 21154349]
Abbreviations
EHR: electronic health record
ER: emergency room
FQHC: federally qualified health center
IT: information technology
mHealth: mobile health
QoL: quality of life
RE-AIM: Reach, Effectiveness, Adoption, Implementation, and Maintenance
Edited by G Eysenbach; submitted 12.09.17; peer-reviewed by P Wicks, K Claborn; comments to author 05.10.17; revised version
received 30.11.17; accepted 22.12.17; published 30.01.18
Please cite as:
Quanbeck A, Gustafson DH, Marsch LA, Chih MY, Kornfield R, McTavish F, Johnson R, Brown RT, Mares ML, Shah DV
Implementing a Mobile Health System to Integrate the Treatment of Addiction Into Primary Care: A Hybrid Implementation-Effectiveness
Study
J Med Internet Res 2018;20(1):e37
URL: http://www.jmir.org/2018/1/e37/ 
doi:10.2196/jmir.8928
PMID:29382624
©Andrew Quanbeck, David H Gustafson, Lisa A Marsch, Ming-Yuan Chih, Rachel Kornfield, Fiona McTavish, Roberta Johnson,
Randall T Brown, Marie-Louise Mares, Dhavan V Shah. Originally published in the Journal of Medical Internet Research
(http://www.jmir.org), 30.01.2018. This is an open-access article distributed under the terms of the Creative Commons Attribution
License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete
bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information
must be included.
J Med Internet Res 2018 | vol. 20 | iss. 1 | e37 | p.16http://www.jmir.org/2018/1/e37/
(page number not for citation purposes)
Quanbeck et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
